A mixture of inhalers delay the asthma progression
Analysis of a phase III trial revealed that a combination of beta2-adrenergic agonist and an inhaled corticosteroid stopped…
Analysis of a phase III trial revealed that a combination of beta2-adrenergic agonist and an inhaled corticosteroid stopped…
In light of the possibility of serious consequences, such as hospitalisation and death, the FDA stated that it…
Drug safety is dependent on monitoring a drug's security after it is made available to patients (a process…